Oligonucleotides for CNS Summit Europe
Discovering, developing, and optimising nucleic acid therapies for precise delivery to undruggable CNS targets.
Date
21–23 April 2026
Location
Hoofddorp, Netherlands
What to Expect:
The inaugural Oligonucleotides for CNS Summit Europe will unite 60+ senior industry leaders for the first European forum dedicated exclusively to CNS-focused Oligonucleotide therapeutics.Â
The summit delivers three days of highly technical, data-driven discussions addressing the challenges unique to CNS development with insight into next-generation BBB delivery strategies beyond TfR1, advanced in vivo and iPSC models, novel chemistry and conjugation approaches, and translational strategies bridging preclinical data to clinical and regulatory success.Â
Noteable Speakers:Â
- Farzaneh Salem, Associate Director, PB/PK Modelling, GSK
- Felix Schumacher, RNA Hub Mission Lead, Roche
- Macarena Hernández, Chief Scientific Officer, AptaTargets
- Duygu Yilmaz, Director RNA therapeutics and Translational Science, Aerska
- Gerard Platenburg, Chief Scientific Officer & Co-Founder, ProQR Therapeutics
- Hélène Tran, Director, Head of Antisense Oligonucleotide Therapeutic Program, Servier
- Søren Rasmussen, Chief Scientific Officer, Contera Pharma
- Jan Thirkettle, Chief Executive Officer, Harness Therapeutics
Find out more in the Event Guide:Â https://ter.li/53i75uÂ
Event details
Novotel Amsterdam Schiphol Airport
Novotel Amsterdam Schiphol Airport, Novotel Amsterdam Schiphol Airport, Taurusavenue 12, Hoofddorp, 2132 LS, Netherlands
Hanson Wade Group